These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4114990)

  • 1. [Treatment with estramustine phosphate in advanced prostatic cancer].
    Klein D
    Wien Med Wochenschr; 1972 Jul; 122(30):458-60. PubMed ID: 4114990
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of rapidly progressing prostatic carcinoma with estracyt.
    Lindberg B
    J Urol; 1972 Aug; 108(2):303-6. PubMed ID: 5047424
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary results of 10 patients with advanced prostatic neoplasm treated with estracyt].
    de Leval J; Petit R; Bouffioux C
    Acta Urol Belg; 1974 Jul; 42(3):326-35. PubMed ID: 4440596
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate.
    Müntzing J; Shukla SK; Chu TM; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):65-8. PubMed ID: 4835492
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of prostatic carcinoma with orally administered Estracyt].
    Mayer EJ
    Ther Umsch; 1975 Feb; 32(2):114-9. PubMed ID: 1118820
    [No Abstract]   [Full Text] [Related]  

  • 6. Estracyt in hormone-resistant prostatic carcinoma.
    Szendröi Z; Könyves I; Szendi L; Eckhardt S; Hartay F
    Int Urol Nephrol; 1974; 6(2):101-10. PubMed ID: 4448622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytostatic treatment of prostatic carcinoma. Evaluation study of estramustinphosphate].
    Anderes A; Arquint A; Camponovo F; Deppeler O; Doerig R; Heim H; Humbert-Droz P; Jung HP; Magaro L; Sasso M; Vischer C; Wanner J; Wegmann HJ; Ziegler E
    Schweiz Rundsch Med Prax; 1971 Sep; 60(38):1276-9. PubMed ID: 5094915
    [No Abstract]   [Full Text] [Related]  

  • 8. Stage D prostatic carcinoma. Survival rate in relapsed patients following new forms of palliation.
    Welvaart K; Merrin CE; Mittelman A; Murphy GP
    Urology; 1974 Sep; 4(3):283-6. PubMed ID: 4138219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of advanced carcinoma of the prostate with estramustine phosphate (estracyt)].
    Lancina Martín JA; Chantada Abal V; Lamas Meilan AC; González Martín M
    Actas Urol Esp; 1984; 8(5):399-402. PubMed ID: 6524487
    [No Abstract]   [Full Text] [Related]  

  • 10. Estracyt (NSC 89199) as a substrate for phosphatases in human serum.
    Tritsch GL; Shukla SK; Mittelman A; Murphy GP
    Invest Urol; 1974 Jul; 12(1):38-9. PubMed ID: 4366126
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent data on the mechanism of action of oestrogens in the treatment of prostatic tumour patients.
    Szendröi Z; Kocsár L; Karika Z; Füzi M; Tarján G; Reischel G; Eckhardt S
    Int Urol Nephrol; 1974; 5(3):311-23. PubMed ID: 4829136
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estramustine phosphate in the treatment of stage D prostatic carcinoma].
    van Wyk J
    S Afr Med J; 1978 Oct; 54(16):638. PubMed ID: 741271
    [No Abstract]   [Full Text] [Related]  

  • 13. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
    Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total remission of prostatic cancer following treatment with Estracyt].
    Romics I
    Orv Hetil; 1982 Jan; 123(5):287-9. PubMed ID: 7063244
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced prostatic carcinoma using estramustinphosphate].
    Ferrer Roda J
    Actas Urol Esp; 1983; 7(1):29-34. PubMed ID: 6192690
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Loening SA; Prout GR; Schmidt JD; Bross DS; Chu TM; Gaeta JF; Saroff J; Scott WW
    J Urol; 1977 Aug; 118(2):288-91. PubMed ID: 142845
    [No Abstract]   [Full Text] [Related]  

  • 18. Disappearance of osteoblastic metastases in prostatic carcinoma following estramustine therapy.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    JAMA; 1977 Jun; 237(23):2471. PubMed ID: 576957
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic treatment of advanced prostatic cancer: development of a new system for defining response.
    Citrin DL; Cohen AI; Harberg J; Schlise S; Hougen C; Benson R
    J Urol; 1981 Feb; 125(2):224-7. PubMed ID: 6259376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.